The Manila Times
Il y a 1 h
Telix Reports Third Quarter 2026 Financial Performance
**media[1269247]**MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix') provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026).Q3 2026 Highlights[1]Group revenue of US$245 million increased 19% over the prior corresponding quarter (Q3 2025) driven by continued strong demand for the commercial portfolio, in line with expectations. September sales drov